PIK3CA hotspot mutations are present at a relatively high frequency in CTCs of operable and metastatic breast cancer patients

被引：0
|
作者：
Markou, Athina N. [1 ]
Farkona, Sofia [1 ]
Schiza, Christina [1 ]
Eftathiou, Antonia [1 ]
Malamos, Nikolaos [2 ]
Georgoulias, Vassilis [3 ]
Lianidou, Evi [1 ]
机构：
[1] Univ Athens, Dept Chem, Anal Circulating Tumor Cells Lab, Analyt Chem Lab, GR-10680 Athens, Greece
[2] Elena Venizelou Hosp, Med Oncol Unit, Athens, Greece
[3] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Greece
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognosis of women with early breast cancer and PIK3CA mutations
    Di Cosimo, Serena
    Bianchi, Giulia Valeria
    Bregni, Giacomo
    de Braud, Filippo
    BREAST, 2015, 24 (03): : 283 - 284
  • [32] PIK3CA mutations in breast cancer: A potential predictive marker
    Santarpia, M.
    Rosell, R.
    Margeli, M.
    Mesiti, M.
    Cavallari, V
    Pitini, V
    Cirauqui, B.
    Reguart, N.
    Barnadas, A.
    Taron, M.
    Altavilla, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI36 - XI36
  • [33] PIK3CA mutations in breast cancer are associated with poor outcome
    Shao Ying Li
    Minna Rong
    Fabienne Grieu
    Barry Iacopetta
    Breast Cancer Research and Treatment, 2006, 96 : 91 - 95
  • [34] Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
    Riener, Marc-Oliver
    Bawohl, Marion
    Clavien, Pierre-Alain
    Jochum, Wolfram
    GENES CHROMOSOMES & CANCER, 2008, 47 (05): : 363 - 367
  • [35] Benefit of CDK4/6 inhibitors beyond PIK3CA mutations in metastatic breast cancer patients
    Tolosa Ortega, P.
    Cejalvo, J. M.
    Moragon Terencio, S.
    Carril-Ajuria, L.
    Bermejo, B.
    Ruiz, A.
    Hernando Melia, C.
    Sanchez-Torre, A.
    Martinez, M. T.
    Herrera, M.
    Gambardella, V.
    Lema, L.
    Roda, D.
    Bernal, E.
    Rentero-Garrido, P.
    Lluch, A.
    Ciruelos, E. M.
    Cervantes, A.
    Manso, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S35 - S35
  • [36] PIK3CA, a hotspot for postzygotic mutations in nonhereditary overgrowth syndromes
    Baradaran-Heravi, Alireza
    CLINICAL GENETICS, 2012, 82 (06) : 523 - 525
  • [37] Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
    Corne, Julien
    Le Du, Fanny
    Quillien, Veronique
    Godey, Florence
    Robert, Lucie
    Bourien, Heloise
    Brunot, Angelique
    Crouzet, Laurence
    Perrin, Christophe
    Lefeuvre-Plesse, Claudia
    Dieras, Veronique
    Rouge, Thibault De la Motte
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] PIK3CA gene mutations in breast carcinoma in Malaysian patients
    Leong, Vincent Ching-Shian
    Jabal, Mohd Faizal
    Leong, Pooi Pooi
    Abdullah, Maizaton Atmadini
    Gul, Yunus Alif
    Seow, Heng Fong
    CANCER GENETICS AND CYTOGENETICS, 2008, 187 (02) : 74 - 79
  • [39] Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
    Julien Corné
    Fanny Le Du
    Véronique Quillien
    Florence Godey
    Lucie Robert
    Héloïse Bourien
    Angélique Brunot
    Laurence Crouzet
    Christophe Perrin
    Claudia Lefeuvre-Plesse
    Véronique Diéras
    Thibault De la Motte Rouge
    Scientific Reports, 11
  • [40] PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
    Xu, Jian-Ming
    Wang, Yan
    Wang, You-Liang
    Wang, Yan
    Liu, Tao
    Ni, Ming
    Li, Man-Sheng
    Lin, Li
    Ge, Fei-Jiao
    Gong, Chun
    Gu, Jun-Yan
    Jia, Ru
    Wang, He-Fei
    Chen, Yu-Ling
    Liu, Rong-Rui
    Zhao, Chuan-Hua
    Tan, Zhao-Li
    Jin, Yang
    Zhu, Yun-Ping
    Ogino, Shuji
    Qian, Zhi-Rong
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4602 - 4616
12345